A model-based meta-analysis of the influence of factors that impact adherence to medications

Journal of Clinical Pharmacy and Therapeutics

Volumn 40, Issue 1, 2015, Pages 24-31

  Assawasuwannakit, P ^a   Braund, R ^a   Duffull, S B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

adherence; age; disease; medication event monitoring system; model based meta analysis; nonlinear mixed effects modelling

Indexed keywords

DRUG;

AGE; ARTICLE; COMPUTER PROGRAM; DATA ANALYSIS; DRUG DOSE REGIMEN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MEDICAL DEVICE; MEDICATION COMPLIANCE; MEDICATION EVENT MONITORING SYSTEM; MODEL BASED META ANALYSIS; MULTIVARIATE ANALYSIS; PRESCRIPTION; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS; DRUG ADMINISTRATION; META ANALYSIS; STATISTICS AND NUMERICAL DATA;

DRUG ADMINISTRATION SCHEDULE; HUMANS; MEDICATION ADHERENCE; MODELS, STATISTICAL;

EID: 84920282499     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12219     Document Type: Article

References (41)

1. Vrijens B, De Geest S, Hughes DA, et al,. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol, 2012; 73: 691-705.
2. Haynes RB,. Compliance in health care. Baltimore, MD: The Johns Hopkins University Press, 1979.
3. Meyer D, Leventhal H, Gutmann M,. Common-sense models of illness: the example of hypertension. Health Psychol, 1985; 4: 115-135.
4. Griffith S,. A review of the factors associated with patient compliance and the taking of prescribed medicines. Br J Gen Pract, 1990; 40: 114-116.
5. Morris LS, Schulz RM,. Patient compliance-an overview. J Clin Pharm Ther, 1992; 17: 283-295.
6. Sharkness CM, Snow DA,. The patient's view of hypertension and compliance. Am J Prev Med, 1992; 8: 141-146.
7. Miller NH,. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med, 1997; 102: 43-49.
8. Claxton AJ, Cramer J, Pierce C,. A systematic review of the associations between dose regimens and medication compliance. Clin Ther, 2001; 23: 1296-1310.
9. Kardas P,. Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother, 2002; 49: 897-903.
10. Maggiolo F, Ripamonti D, Arici C, et al,. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients. HIV Clin Trials, 2002; 3: 371-378.
11. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO, 2003.
12. DiMatteo MR,. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care, 2004; 42: 200-209.
13. DiMatteo MR, Haskard KB, Williams SL,. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care, 2007; 45: 521-528.
14. Ingersoll KS, Cohen J,. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med, 2008; 31: 213-224.
15. Eldred LJ, Wu AW, Chaisson RE, Moore RD,. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol, 1998; 18: 117-125.
16. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA,. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr, 2000; 23: 386-395.
17. Stone VE, Jordan J, Tolson J, Miller R, Pilon T,. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence. J Acquir Immune Defic Syndr, 2004; 36: 808-816.
18. Hulka BS, Cassel JC, Kupper LL, Burdette JA,. Communication, compliance, and concordance between physicians and patients with prescribed medications. Am J Public Health, 1976; 66: 847-853.
19. van der Wal MH, Jaarsma T,. Adherence in heart failure in the elderly: problem and possible solutions. Int J Cardiol, 2008; 125: 203-208.
20. Doggrell SA,. Adherence to medicines in the older-aged with chronic conditions: does intervention by an allied health professional help? Drugs Aging, 2010; 27: 239-254.
21. Urquhart J, De Klerk E,. Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. Stat Med, 1998; 17: 251-267.
22. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL,. How often is medication taken as prescribed? A novel assessment technique JAMA, 1989; 261: 3273-3277.
23. Kastrissios H, Blaschke TF,. Medication compliance as a feature in drug development. Annu Rev Pharmacol Toxicol, 1997; 37: 451-475.
24. Osterberg L, Blaschke T,. Adherence to medication. N Engl J Med, 2005; 353: 487-497.
25. Blaschke TF, Osterberg L, Vrijens B, Urquhart J,. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol, 2012; 52: 275-301.
26. Ahn JE, French JL,. Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation. J Pharmacokinet Pharmacodyn, 2010; 37: 179-201.
27. Mandema JW, Cox E, Alderman J,. Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain-results of a model-based meta-analysis that accounts for encapsulation. Cephalalgia, 2005; 25: 715-725.
28. Ito K, Ahadieh S, Corrigan B, French J, Fullerton T, Tensfeldt T,. Disease progression meta-analysis model in Alzheimer's disease. Alzheimers Dement, 2010; 6: 39-53.
29. Demin I, Hamren B, Luttringer O, Pillai G, Jung T,. Longitudinal model-based meta-analysis in rheumatoid arthritis: an application toward model-based drug development. Clin Pharmacol Ther, 2012; 92: 352-359.
30. Gross JL, Rogers J, Polhamus D, et al,. A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment of type 2 diabetes mellitus. BMJ Open, 2013; 3: 267-273.
31. Paterson DL, Swindells S, Mohr J, et al,. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med, 2000; 133: 21-30.
32. Hinkin CH, Hardy DJ, Mason KI, et al,. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS, 2004; 18 (Suppl 1): S19-S25.
33. Kastrissios H, Suarez JR, Katzenstein D, Girard P, Sheiner LB, Blaschke TF,. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial. AIDS, 1998; 12: 2295-2303.
34. Kiortsis DN, Giral P, Bruckert E, Turpin G,. Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients. J Clin Pharm Ther, 2000; 25: 445-451.
35. Coons SJ, Sheahan SL, Martin SS, Hendricks J, Robbins CA, Johnson JA,. Predictors of medication noncompliance in a sample of older adults. Clin Ther, 1994; 16: 110-117.
36. Farmer KC, Jacobs EW, Phillips CR,. Long-term patient compliance with prescribed regimens of calcium channel blockers. Clin Ther, 1994; 16: 316-326.
37. Lau HS, Beuning KS, Postma-Lim E, Klein-Beernink L, de Boer A, Porsius AJ,. Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis. Pharm World Sci, 1996; 18: 63-68.
38. Morrell RW, Park DC, Kidder DP, Martin M,. Adherence to Antihypertensive Medications Across the Life Span. Gerontologist, 1997; 37: 609-619.
39. Park DC, Hertzog C, Leventhal H, et al,. Medication adherence in rheumatoid arthritis patients: older is wiser. J Am Geriatr Soc, 1999; 47: 172-183.
40. Park DC, Morrell RW, Frieske D, Kincaid D,. Medication adherence behaviors in older adults: effects of external cognitive supports. Psychol Aging, 1992; 7: 252-256.
41. Lee JK, Grace KA, Taylor AJ,. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA, 2006; 296: 2563-2571.